Literature DB >> 19932172

c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

Jae J Song1, Miroslaw Jerzy Szczepanski, So Young Kim, Joo-Hang Kim, Jee Young An, Yong Tae Kwon, Marco A Alcala, David L Bartlett, Yong J Lee.   

Abstract

We previously reported two modes of development of acquired TRAIL resistance: early phase and late phase [1]. In these studies, we observed that greater Akt activity and the expression of Bcl-xL were related mainly to the late phase of acquired TRAIL resistance. Recently we became aware of a possible mechanism of early phase TRAIL resistance development through internalization and degradation of TRAIL receptors (DR4 and DR5). Our current studies demonstrate that TRAIL receptors rapidly diminish at the membrane as well as the cytoplasm within 4h after TRAIL exposure, but recover completely after one or two days. Our studies also reveal that Cbl, a ubiquitously expressed cytoplasmic adaptor protein, is responsible for the rapid degradation of TRAIL receptors; Cbl binds to them and induces monoubiquitination of these receptors concurrent with their degeneration soon after TRAIL exposure, creating the early phase of acquired TRAIL resistance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19932172      PMCID: PMC2973327          DOI: 10.1016/j.cellsig.2009.11.012

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  43 in total

1.  Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.

Authors:  H Take; S Watanabe; K Takeda; Z X Yu; N Iwata; S Kajigaya
Journal:  Biochem Biophys Res Commun       Date:  2000-02-16       Impact factor: 3.575

Review 2.  Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases.

Authors:  H Waterman; Y Yarden
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

Review 3.  The Cbl family: ubiquitin ligases regulating signaling by tyrosine kinases.

Authors:  A Sanjay; W C Horne; R Baron
Journal:  Sci STKE       Date:  2001-11-27

4.  Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.

Authors:  G Levkowitz; H Waterman; S A Ettenberg; M Katz; A Y Tsygankov; I Alroy; S Lavi; K Iwai; Y Reiss; A Ciechanover; S Lipkowitz; Y Yarden
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

5.  Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL.

Authors:  Jae J Song; Jee Young An; Yong Tae Kwon; Yong J Lee
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

6.  Recognition of the tryptophan-based endocytosis signal in the neonatal Fc Receptor by the mu subunit of adaptor protein-2.

Authors:  Naomi L B Wernick; Volker Haucke; Neil E Simister
Journal:  J Biol Chem       Date:  2004-12-14       Impact factor: 5.157

7.  Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.

Authors:  X D Zhang; A V Franco; T Nguyen; C P Gray; P Hersey
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

8.  Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors.

Authors:  Philippe Soubeyran; Katarzyna Kowanetz; Iwona Szymkiewicz; Wallace Y Langdon; Ivan Dikic
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

Review 9.  Cbl: many adaptations to regulate protein tyrosine kinases.

Authors:  C B Thien; W Y Langdon
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 10.  Beyond the RING: CBL proteins as multivalent adapters.

Authors:  A Y Tsygankov; A M Teckchandani; E A Feshchenko; G Swaminathan
Journal:  Oncogene       Date:  2001-10-01       Impact factor: 9.867

View more
  25 in total

1.  Structural basis for autoinhibition and phosphorylation-dependent activation of c-Cbl.

Authors:  Hao Dou; Lori Buetow; Andreas Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

2.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

3.  Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells.

Authors:  Shunchao Yan; Xiujuan Qu; Chong'an Xu; Zhitu Zhu; Lingyun Zhang; Ling Xu; Na Song; Yuee Teng; Yunpeng Liu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

4.  Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response.

Authors:  Gu-Choul Shin; Hong Seok Kang; Ah Ram Lee; Kyun-Hwan Kim
Journal:  Autophagy       Date:  2016-10-14       Impact factor: 16.016

5.  Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt Pathway.

Authors:  Wei Jin; Wei Xu; Xiaoxiao Zhang; Chuan-Cheng Ren
Journal:  Mol Neurobiol       Date:  2020-06-20       Impact factor: 5.590

6.  Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.

Authors:  Marika Ciprotti; Niall C Tebbutt; Fook-Thean Lee; Sze-Ting Lee; Hui K Gan; David C McKee; Graeme J O'Keefe; Sylvia J Gong; Geoffrey Chong; Wendie Hopkins; Bridget Chappell; Fiona E Scott; Martin W Brechbiel; Archie N Tse; Mendel Jansen; Manabu Matsumura; Masakatsu Kotsuma; Rira Watanabe; Ralph Venhaus; Robert A Beckman; Jonathan Greenberg; Andrew M Scott
Journal:  J Clin Oncol       Date:  2015-06-29       Impact factor: 44.544

7.  Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.

Authors:  Young Dong Yoo; Dae-Hee Lee; Hyunjoo Cha-Molstad; Hyungsin Kim; Su Ran Mun; Changhoon Ji; Seong Hye Park; Ki Sa Sung; Seung Ah Choi; Joonsung Hwang; Deric M Park; Seung-Ki Kim; Kyung-Jae Park; Shin-Hyuk Kang; Sang Cheul Oh; Aaron Ciechanover; Yong J Lee; Bo Yeon Kim; Yong Tae Kwon
Journal:  EMBO Rep       Date:  2016-12-19       Impact factor: 8.807

8.  TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.

Authors:  Bo K Sun; Joo-Hang Kim; Hoan N Nguyen; So Y Kim; Seeun Oh; Yong J Lee; Jae J Song
Journal:  Int J Oncol       Date:  2011-01       Impact factor: 5.650

9.  Monocyte chemotactic protein-induced protein-1 enhances DR5 degradation and negatively regulates DR5 activation-induced apoptosis through its deubiquitinase function.

Authors:  You-Take Oh; Guoqing Qian; Jiusheng Deng; Shi-Yong Sun
Journal:  Oncogene       Date:  2018-03-19       Impact factor: 9.867

10.  mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis.

Authors:  Liqun Zhao; Ping Yue; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.